Condition
Gastrointestinal Lesions
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 4 (1)
Trial Status
Completed2
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05468008Recruiting
Endoscopic Submucosal Dissection (ESD)
NCT05226221Recruiting
Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality
NCT02632812Phase 1CompletedPrimary
Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo
NCT00652834Phase 4CompletedPrimary
Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®
Showing all 4 trials